These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37951061)

  • 21. Pro-Resolving Lipid Mediator Resolvin E1 Mitigates the Progress of Diethylnitrosamine-Induced Liver Fibrosis in Sprague-Dawley Rats by Attenuating Fibrogenesis and Restricting Proliferation.
    Rodríguez MJ; Herrera F; Donoso W; Castillo I; Orrego R; González DR; Zúñiga-Hernández J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitory effect of
    Feng M; He S; Huang S; Lin J; Yang H; Wang J; Pang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1148-1154. PubMed ID: 32895174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
    J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effect of hydrazinocurcumin on carcinogenesis of diethylnitrosamine-induced hepatocarcinoma in male SD rats.
    Zhao JA; Peng L; Geng CZ; Liu YP; Wang X; Yang HC; Wang SJ
    Asian Pac J Cancer Prev; 2014; 15(5):2115-21. PubMed ID: 24716943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
    PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal Consumption of a Low-Isoflavone Soy Protein Isolate Diet Accelerates Chemically Induced Hepatic Carcinogenesis in Male Rat Offspring.
    Choi J; Won SB; Kwon YH
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32098370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
    El-Ahwany E; Mansy SS; Zoheiry M; Mourad L; Mahmoud S; Abu-Taleb H; Hassanien M; Hassan M
    Ultrastruct Pathol; 2020 Mar; 44(2):203-210. PubMed ID: 32216509
    [No Abstract]   [Full Text] [Related]  

  • 28. Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway.
    Ding J; Qi C; Li J; Huang C; Zhang J; Zhang Y; Li Y; Fan B
    Med Sci Monit; 2021 Aug; 27():e929255. PubMed ID: 34344856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonorchis sinensis infection contributes to hepatocellular carcinoma progression in rat.
    Qi Y; Hu J; Liang J; Hu X; Ma N; Xiang B
    Parasitol Res; 2022 Dec; 121(12):3403-3415. PubMed ID: 36266591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats.
    Saleem S; Kazmi I; Ahmad A; Abuzinadah MF; Samkari A; Alkrathy HM; Khan R
    Nutr Cancer; 2020; 72(1):170-181. PubMed ID: 31088230
    [No Abstract]   [Full Text] [Related]  

  • 31. Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma.
    Zhou W; Zheng Y; Shang J; Wang H; Wang Y; Lu H; Wang X; Sui M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):438-453. PubMed ID: 37202098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemopreventive and Therapeutic Efficacy of Enhalus acoroides against Diethylnitrosamine Induced Hepatocellular Carcinoma in Wistar Albino Rats.
    Amudha P; Jayalakshmi M; Vidya R; Poojitha BN
    Appl Biochem Biotechnol; 2023 Apr; 195(4):2597-2617. PubMed ID: 35106713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
    Memon A; Pyao Y; Jung Y; Lee JI; Lee WK
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells.
    Song SS; Yuan PF; Li PP; Wu HX; Ni WJ; Lu JT; Wei W
    Immunol Invest; 2015; 44(6):521-35. PubMed ID: 26207789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis.
    Ha WS; Kim CK; Song SH; Kang CB
    J Vet Sci; 2001 Apr; 2(1):53-8. PubMed ID: 14614295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway.
    Chen Y; Song Z; Hou X; Liu J; Zheng C; Zhao X; Lv G; Li J; Xiu Y; Shi W; Zhao J; Yang H; Wang Y; Zhao J; Zhan X; Niu M; Zou W; Bai Z; Xiao X
    J Ethnopharmacol; 2024 Mar; 321():117406. PubMed ID: 37952733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats.
    Ghosh A; Ghosh D; Sarkar S; Mandal AK; Thakur Choudhury S; Das N
    Eur J Cancer Prev; 2012 Jan; 21(1):32-41. PubMed ID: 21968689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylaminofluorene- Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling.
    Ali G; Omar H; Hersi F; Abo-Youssef A; Ahmed O; Mohamed W
    Curr Mol Pharmacol; 2022; 15(1):252-262. PubMed ID: 34238176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.